Clinical Trial Update: EPAT: Estrogen in the Prevention of Atherosclerosis Trial [Phase 2, Phase 3]

View source ↗

Summary

The EPAT trial evaluating estrogen for the prevention of atherosclerosis in postmenopausal women has completed its Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Atherosclerosis, Postmenopause | Phase 2, Phase 3 | Status: COMPLETED